AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP

Camperdown, New South Wales, 2050 Australia

Mission Statement

The GI Cancer Institute funds vital Gastro-Intestinal (GI cancer) research to improve treatment options and the quality of life for people living with GI cancers.

About This Cause

Gastro-Intestinal (GI) cancer is the most common form of cancer claiming a devastating 51 lives each day. At the GI Cancer Institute, our vision is to create a world free from GI cancers. We fund clinical trials research to improve quality of life and treatment options for GI cancer patients. GI cancers affect the digestive system and include cancers of the stomach, oesophagus, gallbladder, liver, pancreas, stomach, bowel and anus. Conducting clinical trials in Australia means patients can access the latest GI cancer treatments three to five years earlier than if those trials were conducted overseas. Major advances in treating GI cancers and improving patient quality of life are possible as a result of community support for funding.

AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP
Level 6, 119-143 Missenden Rd 119 - 143 Missenden Road
Camperdown, New South Wales 2050
Australia
Phone 1300 666 769
Twitter @GICancer
Unique Identifier 34093854267